Trademark: 77887516
Word
RESTAT THE POWER OF RE.
Status Date
Monday, July 2, 2012
Filing Date
Monday, December 7, 2009
Published for Opposition
Tuesday, October 4, 2011
Abandoned Date
Monday, July 2, 2012
35 Providing a secure website allowing prescription drug users to review prescription information on incentives to promote generic and formulary drug utilization; prescription drug benefit management services, namely, pharmaceutical cost management services, drug utilization review services; health benefits management services, namely, cost management for the health benefit plans of others; providing information online in the field of health care benefits, namely, information about cost management for the health benefit plans of others and public advocacy to promote awareness of patient needs and rights; business administration services for others, namely, design of employee benefit plans and design and administration of prescription card systems; providing a searchable online evaluation tool, namely, an online searchable database featuring information relating to quality, pricing, and features of health related benefits, namely, information on cost management of health benefit plans and cost and service comparison of pharmacy-related products and services; medical claims management services, namely, providing pricing incentives and cost savings programs in the field of benefits management; providing information online regarding prescriptions and pharmaceuticals, namely, prescription and pharmaceutical pricing
36 Providing a secure website allowing prescription drug users to review prescription information on-line, namely, information regarding payment coordination with primary or secondary carriers; insurance claims processing/adjustment services; providing information online regarding prescriptions and pharmaceuticals, namely, prescription and pharmaceutical insurance coverage information
42 Pharmacy review services, namely, providing quality control services for the pharmaceutical industry
44 Providing a secure website allowing prescription drug users to review prescription information on-line namely, drug selection and utilization, authorization for drug utilization, and formulary overrides; providing information online regarding healthy lifestyles, wellness programs, and prescriptions and pharmaceuticals, namely, prescription and pharmaceutical safety, use and side effect information
The color(s) orange and gray is/are claimed as a feature of the mark.
The mark consists of the word "RESTAT" with the letters "RE" written in orange and the letters "STAT" written in gray above the words "THE POWER OF" written in gray followed by "RE" written in orange and a gray period.
Jul 2, 2012
Abandonment Notice Mailed - No Use Statement Filed
Jul 2, 2012
Abandonment - No Use Statement Filed
Nov 29, 2011
Noa E-Mailed - Sou Required From Applicant
Oct 4, 2011
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2011
Official Gazette Publication Confirmation E-Mailed
Oct 4, 2011
Published For Opposition
Aug 30, 2011
Law Office Publication Review Completed
Aug 25, 2011
Approved For Pub - Principal Register
Aug 25, 2011
Examiner's Amendment Entered
Aug 25, 2011
Notification Of Examiners Amendment E-Mailed
Aug 25, 2011
Examiners Amendment E-Mailed
Aug 25, 2011
Examiners Amendment -Written
Apr 13, 2011
Teas/Email Correspondence Entered
Apr 12, 2011
Correspondence Received In Law Office
Apr 12, 2011
Teas Request For Reconsideration Received
Oct 13, 2010
Notification Of Final Refusal Emailed
Oct 13, 2010
Final Refusal E-Mailed
Oct 13, 2010
Final Refusal Written
Sep 22, 2010
Teas/Email Correspondence Entered
Sep 22, 2010
Correspondence Received In Law Office
Sep 22, 2010
Assigned To Lie
Sep 10, 2010
Teas Response To Office Action Received
Mar 11, 2010
Notification Of Non-Final Action E-Mailed
Mar 11, 2010
Non-Final Action E-Mailed
Mar 11, 2010
Non-Final Action Written
Mar 10, 2010
Assigned To Examiner
Dec 11, 2009
New Application Office Supplied Data Entered In Tram
Dec 10, 2009
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
